SpaceX vs. Tesla: Here's Which Elon Musk Stock I'd Buy Right Now

SpaceX generated $19.3 billion of revenue over the past year but lost $8.7 billion, while Tesla produced about $98 billion in annual sales with a 4.9% operating margin and $7 billion in positive free cash flow. The article argues both stocks are priced on long-dated bets: SpaceX on AI and Tesla on humanoid robots, with SpaceX's AI division assigned a $26.5 trillion TAM. The piece is primarily valuation commentary rather than a new company catalyst, so near-term stock impact should be limited.

Analysis

The market is being asked to price two long-duration optionality stories, but only one has an underwriting base. The cleaner setup is TSLA: even if the robotics narrative remains a call option, the business already throws off cash and has a financing structure that can absorb disappointment; that makes the equity more resilient to multiple compression if rates stay sticky. By contrast, SpaceX-like private-market marks tied to AI/adjacent moonshots are more fragile because they depend on future financing rounds or monetization milestones rather than current earnings power.

Second-order, the article is really about capital allocation at the frontier of venture-style public/late-private investing. If the market starts rewarding profit-bearing cores over speculative AI add-ons, capital could rotate away from high-beta private market names with weak unit economics and toward infrastructure winners that monetize picks-and-shovels demand. That would be a relative tailwind for compute, networking, and power-enablement suppliers, while pressuring any company whose valuation depends on a single heroic TAM assumption.

The key risk is not whether the stories are exciting, but whether the time horizon is longer than investor patience. A 12-24 month window with no visible operating leverage can trigger sharp drawdowns even in admired franchises, especially if funding conditions tighten or if the cost of capital rises further. The contrarian miss is that the ‘boring’ profitable core may deserve a premium for survivability, while the market is likely overpaying for the right to believe in multiple decades of execution without evidence.

Key Decisions for Investors

• Long TSLA vs. a basket of unprofitable AI/private-market proxies for a 6-12 month horizon; thesis is that the market will reprice toward cash-generating franchises if growth disappoints and rates remain elevated.
• Avoid initiating new exposure to headline-driven private-market AI optionality at implied valuations that assume near-term monetization; require at least one financing/launch milestone before paying growth multiples.
• Add selectively to NVDA on pullbacks as the cleaner second-order beneficiary of any capital rotation into real AI infrastructure demand; use 3-6 month timeframes and keep it as a relative winner, not a broad AI-beta trade.
• Use TSLA call spreads rather than outright stock for upside participation over 12 months; the core business underwrites downside better than the market’s robotics option does, but the multiple can still compress.
• If you already own speculative frontier-tech exposure, pair it against TSLA or profitable megacap tech rather than cash; the objective is to isolate narrative risk from balance-sheet risk.